Navigation Links
Renal Denervation Devices Market - Global Industry Analysis, Size, Share, Growth, and Forecast, 2012 - 2021
Date:1/3/2014

DUBLIN, January 3, 2014 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/xdj2p5/renal_denervation) has announced the addition of the "Renal Denervation Devices (Symplicity, EnligHTN, OneShot, V2, Paradise, TIVUS, Bullfrog, Surround Sound, Micro-Infusion, Ultrasound and Radiofrequency) Market - Global Industry Analysis, Size, Share, Growth, and Forecast, 2012 - 2021" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

The study comprises of a strategic analysis of the global market for renal denervation devices, and growth forecast for the period from 2012 - 2021. The scope of the report includes competitive analysis of various market segments based on the product, technology and in-depth scrutiny for different regional markets such as North America, Europe, Asia-Pacific and the rest of the world. The Porter's Five Forces analysis included in the report provides an insight into market dynamics and industry competition. The report also offers a PESTLE analysis on the market segments with regards to the future, segregated in different chapters. The report details across from 2012 to 2021 which includes the information of all projected activities in every phase of the report. The market forecast has been separated in three groups of years (2012-2015, 2015-2018 and 2018-2021) to include a separate analysis of each group. The unique analysis in this way covers all current and predicted future activities though this period and highlights key milestones in the progress of this market in the coming years.

This report provides complete insights on the RDN devices market and also analyzes various factors responsible for market growth. These factors determine various existing trends and their impact on market growth. In all, the report includes a holistic analysis of the global renal denervation devices market, and provides an estimate of growth for the period 2012 - 2021, keeping in mind the various factors affecting the market.

This report also analyzes current trends for hypertension treatment methods and advantages of renal denervation systems over other methods which act as a catalyst for the growth in the market. The report provides analysis of the most popular RDN device platforms such as Medtronic's Symplicity, Covidien's OneShot, Boston Scientific's (Vessix Vascular) V2 system, and other emerging devices which will enable stakeholders to map their strategies.

The report also analyzes growth strategies implemented by existing players which will guide emerging players to develop their own strategies and helps existing players to structure their planning process. The report also includes entry barriers to be considered to cater to the exact business opportunities in this market. Additionally, to aid in tactical decision making, the report also includes competitive profiling of leading players, recent developments in the industry and various business strategies adopted by them. This report will help manufacturers, suppliers and distributors in the renal denervation field to plan and implement their roadmap in different market areas such as emerging geographies and new technologies.


Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Executive Summary

Chapter 3 Global Renal Denervation Devices Market Analysis

Chapter 4 Global Renal Denervation Devices Market Analysis, By Technology

Chapter 5 Global Renal Denervation Devices Market Analysis, By Products

Chapter 6 Renal Denervation Market Analysis, By Geography

Chapter 7 Competitive Analysis: Renal Denervation Market


Companies Mentioned:

  • Boston Scientific Corporation
  • CardioSonic
  • Covidien PLC
  • Kona Medical
  • Medtronic Inc.
  • Mercator Medsystems
  • St.Jude Medical

For more information visit http://www.researchandmarkets.com/research/xdj2p5/renal_denervation


Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net

 


'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Global Renal Denervation Devices Market 2012-2016
2. 3SBio to Develop DJ5 for Progressive Renal Failure in ADPKD Patients
3. LX4211 Achieves Positive Results in Type 2 Diabetes Patients with Renal Impairment
4. Novartiss Serelaxin Has the Potential to Fulfill the Most Pertinent Unmet Needs in Acute Heart Failure by Reducing the Rate of Patient Mortality and the Rate of Worsening Renal Function
5. New data about the safety and efficacy of linagliptin in adults with type 2 diabetes who have moderate to severe renal impairment presented at ADA
6. TVA Medical Raises $9.5 Million to Advance Minimally Invasive Therapy for End-Stage Renal Disease
7. AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy
8. Pentec Health Announces Limited Voluntary Recall of Certain Compounded Prescription Therapies for Renal Patients
9. In Pretreated Advanced Renal Cell Carcinoma, Thought Leaders Opinions and Clinical Data Indicate that Tivopath Has Efficacy and Tolerability Advantages Over Currently Used Therapies
10. U.S. Physicians Report Diabetic Nephropathy as the Renal Condition with the Highest Unmet Need for Treatment
11. A Novel Oral Anticoagulant is Planned to be Developed for Patients with Prosthetic Heart Valves or Chronic Renal Dysfunction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Research and Markets has announced the addition of ... report to their offering. ... The World Market for Companion Diagnostics covers the world market ... the report includes the following: , World ... Region (N. America, EU, ROW), 2015-2020 , World IVD ...
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Conference and Scientific Sessions in Dallas that it will receive two significant new ... the grants came as PHA marked its 25th anniversary by recognizing patients, medical ...
(Date:6/24/2016)... ... ... makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum ... by 2020 and then adjusting it yearly to increase at the same rate as the ... wage floor does not erode again, and make future increases more predictable. , The company ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Grove Investment Group (TGIG), has initiated cultivation and processing operations at its production ... and Pahrump, Nevada. , Puradigm is the manufacturer of a complete system of ...
Breaking Medicine News(10 mins):